Zhendong (Tom) Cao retweeted
While our judges deliberate the top 3 winners of MSK Postdoc Slam, let’s celebrate our #NPAW2025 📸 contest champs! 🎉
🥇 @MeganEKelley – Sfeir lab
🥈 @TomZhendong – @SawyersLabMSKCC
🥉 Manendra Lankadasari – @JonesDavid2013 lab
Congrats to our amazing #MSKPostdocs @MSKPDA! 👏📷

ALT NPAW 2025 photo contest winners Penni for our thoughts - Megan E. Kelley (Sfeir Lab) May your generating station for science never stop, and may it kiss the skyline with a touch of beauty - Zhendong Cao (Sawyers Lab) Who needs WiFi when the universe is streaming live above your tent? - Manendra Lankadasari (Jones Lab)
Excited to see this! @kristaa122995 beautiful work
(1/n) Excited to share our new preprint! We uncover that RNA actively promotes nucleation and function of pathogenic condensates, amplifying locus-specific oncogenic transcription and promoting tumorigenesis. #epigenetics #condensates #cancer #RNA biorxiv.org/content/10.1101/…
236
Haven't used X for a long while, now excited to see one of my PhD projects finally published in @CD_AACR! Grateful for this tremendous collaboration. Thank you @AbdelWahablab @junwei_s @DaniyanMd @PuZhang09980432
Excited to announce a new paper in @CD_AACR with @junwei_s, @TomZhendong, @DaniyanMd and led by @PuZhang09980432. We perform screens of GAPs and GEFs in AML and discover a hematopoietic-specific GAP (ARHGAP45) required in AML:
aacrjournals.org/cancerdisco…
Zhendong (Tom) Cao retweeted
Excited to share our new study, in close collaboration with @AbdelWahablab and @DaniyanMd led by the exceptionally talented scientists @PuZhang09980432 and @TomZhendong
doi.org/10.1158/2159-8290.CD…
Zhendong (Tom) Cao retweeted
Excited to share that my first author paper entitled “Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignancies” is out on @CD_AACR.
In the study, we used domain-focused CRISPR functional genomics and epistasis screen to systematically map GAPs and GEFs in cancer in vivo and in vitro, uncovering ARHGAP45 as a shared dependency across blood cancers but dispensable for normal blood cells.
Highlights:
1)Using a modified sgRNA expression vector that permits dual genetic perturbation, we systematically perturbed 1,293 gene pairs by pairing ARHGAP45 with pooled sgRNA libraries against 173 GAPs, 103 GEFs, 170 GTPases, 246 glycosylation factors, and 601 kinases annotated in the human genome.
2)ARHGAP45 maintains leukemia stemness by regulating RhoA and CDC42 activity. We found that 'Goldilocks' effect of RhoA strikes a balance between a tumor suppressor and a tumor driver.
3)Our screens identified GMIP (also known as ARHGAP46) as a synergistic partner. GMIP, which clusters closely with ARHGAP45 in phylogenetic analyses, was shown to physically interact with ARHGAP45 by IP-MS analysis, suggesting that dual perturbation of these functionally redundant proteins may further impair leukemia cell growth. Unexpectedly, GTPases such as KRAS and CDC42, along with SOS1, the GEF of KRAS, showed synergistic genetic interactions with ARHGAP45, implying possible counteractive pathways of KRAS or CDC42 GTPase against RhoA.
4) We developed a novel and potent HA-1H–targeting single chain TCR T cells against ARHGAP45-derived minor histocompatibility antigen-presenting cancers.
5) CDC42 inhibition boosts HA-1H antigen presentation and ARHGAP45-targeted cell therapy for potent anti-leukemia effects in mice.
Proud to see this work pave the way for precision immunotherapies in hematologic malignancies.
Thanks to my postdoctoral mentor, @AbdelWahablab, for his great mentorship. The work was impossible without the guidance from @junwei_s, @TomZhendong, @DaniyanMd. Thanks to @Gravity_X_Pan for his expert analysis of patient single cell data.
Excited to announce a new paper in @CD_AACR with @junwei_s, @TomZhendong, @DaniyanMd and led by @PuZhang09980432. We perform screens of GAPs and GEFs in AML and discover a hematopoietic-specific GAP (ARHGAP45) required in AML:
aacrjournals.org/cancerdisco…
Zhendong (Tom) Cao retweeted
Now online in @CD_AACR: Systematic Evaluation of GAPs and GEFs Identifies a Targetable Dependency for Hematopoietic Malignancies - by @PuZhang09980432, @TomZhendong, @DaniyanMd, @AbdelWahablab, @junwei_s, and colleagues doi.org/10.1158/2159-8290.CD… @PennCancer @MSKCancerCenter
Excited for you!!!
congratulations to @kristaa122995 for becoming a Ph.D. candidate! so proud of you and can't wait to see the great things you will achieve next! @PennCBP @CAMBUpenn @Penn_CBIO #ProudPI
2
Zhendong (Tom) Cao retweeted
Our newest paper is out in @CellCellPress today! Janko Gospocic (Bonasio Lab @PennCDB and our own Karl Glastad @Laevorotatory report that transcription factor Kr-h1 regulates "socially appropriate" genes in H. saltator ants to maintain specific castes. 🐜👑
A single protein triggers H. saltator ants' unusual switch from foraging workers into a more queen-like state, shedding light on the molecular boundaries of ant social caste behavior. Read more in @CellCellPress: cell.com/cell/fulltext/S0092…
@berger_lab, @PennCDB Roberto Bonasio
Zhendong (Tom) Cao retweeted
Congrats!!!!!
1/Excited to share my first author publication where we create split-engineered base editors (seBEs). Here, we place base editors under the control of a small-molecule to regulate the timing of genome editing and decrease off-target effects. To achieve it: nature.com/articles/s41589-0…
1
1
Zhendong (Tom) Cao retweeted
Super excited to say our paper investigating macrophage-tumor interactions is now out in Nature! nature.com/articles/s41586-0…
Amazing work by the exceptionally talented Dr. Roarke Kamber @RoarkeKamber, who drove the project from conception to completion w/great collab. team! (1/5)
Zhendong (Tom) Cao retweeted
Single-cell Ribo-seq reveals cell cycle-dependent translational pausing | @Nature nature.com/articles/s41586-0…
Zhendong (Tom) Cao retweeted
Our paper describing TooManyPeaks software for visualization, clustering, and annotation of scATAC-seq data is eventually out at @CellReports. cell.com/cell-reports/fullte…. @PennEpiInst @PennPathLabMed
Zhendong (Tom) Cao retweeted
If you're interested in exploring how cells mend their “breaks”, come join us. We are seeking undergrads, graduate students, technicians and postdocs who can bring along their enthusiasm to study DNA repair and add diversity to our group! vermalab.org
@WUSTLmed Pls RT
Getting back to Twitter today and very excited to share my work on AML pathogenesis!! Really appreciate @junwei_s's great mentorship, fantastic lab mates and collaborators!! Can never accomplish this without your tremendous inputs.
We are thrilled to share our latest publication at @MolecularCell about a multiple PTM reader ZMYND8 in regulating an AML-specific TF circuit! authors.elsevier.com/c/1dX3Z…
Zhendong (Tom) Cao retweeted
2021 is off to a great start! I’m very excited to share my new study at @CellStemCell on using surface antigen-guided CRISPR screens to identify genes that regulate myeloid leukemia differentiation.
cell.com/cell-stem-cell/full…
Zhendong (Tom) Cao retweeted
Enhancer therapy - it works! Successful CRISPR-Cas9 therapy targeting the BCL11A erythroid-specific enhancer in β-thalassemia (TDT) and sickle cell disease (SCD):
nejm.org/doi/full/10.1056/NE…
Zhendong (Tom) Cao retweeted
The Rise of Molecular Glues: cell.com/cell/fulltext/S0092…
Zhendong (Tom) Cao retweeted
why not end the year with some genomic sorcery from @JD_Buenrostro @eboyden3 and team! science.sciencemag.org/conte…
Zhendong (Tom) Cao retweeted
Check out our latest paper in @MolecularCell. The AML1-ETO (AE) team, led by Kristy Stengel, combined the dTAG system with nascent transcript analysis to define a core regulatory network and look at the mechanisms of depression at these targets.
https://teapawt.org/t.co/ecb6yvOlwh
























